A Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims

Simply Wall St.

Jun 06

Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2641252321"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2641252321\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2641252321?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-06-06 09:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641252321","market":"nz","top_or_hot":-1,"title":"A Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims","media":"Simply Wall St.","content":"<div>\n<p>Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-as-insider-bu\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-06 09:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-as-insider-bu><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-as-insider-bu\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-as-insider-bu","article_id":"2641252321","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-mmsi/merit-medical-systems/news/a-look-at-merit-medical-systems-mmsi-valuation-as-insider-bu","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2641252321","pubTimestamp":1780708881,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a challenging year.\nSee our latest analysis for Merit Medical Systems.\nMerit Medical Systems' recent 1 month share price return of 4.62% comes after a tougher spell, with the 90 day share price return down 11.26% and the 1 year total shareholder return down 32.33%. As a result, recent gains look...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","LU0566484027.USD":"安本美国小盘成长股","MMSI":"Merit Medical Systems","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H"},"translate_title":"价值医疗系统(MMSI)估值一览，内部人士在低估指控后买入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMSI":1.5},"content_text":"Recent commentary around Merit Medical Systems (MMSI) has zeroed in on valuation, with intrinsic value and discounted cash flow models suggesting the stock may be pricing in a cautious outlook after a challenging year. See our latest analysis for Merit Medical Systems. Merit Medical Systems' recent 1 month share price return of 4.62% comes after a tougher spell, with the 90 day share price return down 11.26% and the 1 year total shareholder return down 32.33%. As a result, recent gains look more like a tentative stabilisation than a full change in momentum. If you are weighing Merit alongside other healthcare names, this can be a moment to scan for opportunities in medical technology using our screener of 39 healthcare AI stocks With the share price down sharply over 1 year, yet trading at an estimated 34.1% discount to intrinsic value and roughly 38.9% below analyst targets, investors are left with a key question: is this a genuine mispricing, or is the market already accounting for future growth? AdvertisementMost Popular Narrative: 28% Undervalued At a last close of $64.48 against a fair value estimate of $89.55, the prevailing narrative sees Merit Medical Systems trading at a meaningful discount, with that gap underpinned by detailed forecasts for revenue, margins and cash flows.  The expanding global prevalence of chronic diseases and an aging population are increasing the need for interventional, diagnostic, and therapeutic medical procedures. Merit's strong growth in cardiovascular and endoscopy segments, robust new product development, and recent acquisitions (such as Biolife and EndoGastric) position the company to capture a larger share of this growing market and drive sustained long-term revenue growth.  Read the complete narrative. Want to see what kind of revenue climb, margin profile and future earnings multiple have to line up to support that valuation gap? The full narrative lays out a tight set of assumptions on growth, profitability and the price investors might be willing to pay if those targets are hit. Result: Fair Value of $89.55 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this hinges on securing WRAPSODY CIE reimbursement and avoiding further China weakness, where volume based purchasing and softer demand have already pressured international revenue. Find out about the key risks to this Merit Medical Systems narrative. Another View: What The P/E Ratio Is Saying The discount to fair value and analyst targets tells only part of the story. On current numbers, Merit trades on a P/E of 27.6x, which is higher than the US Medical Equipment industry at 25.3x and above its own fair ratio estimate of 21.5x, yet still below a 38.9x peer average. For you, that mix of premium to the sector but discount to peers raises a simple question: is the risk skewed toward the valuation catching up to fundamentals, or the fundamentals catching up to the price? To see how this compares across peers and what that gap could mean if the market moves closer to the fair ratio, have a look at the See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:MMSI P/E Ratio as at Jun 2026Next Steps Is the market being too cautious, or simply realistic about the story so far? Take a closer look at the full picture, including the 4 key rewards. Looking for more investment ideas? If you stop with just one stock, you risk missing other opportunities that might suit your goals even better, so keep widening your watchlist with focused screeners.  Hunt for potential bargains with solid fundamentals by checking companies in the 49 high quality undervalued stocks. Prioritise resilience and sleep a little easier at night by screening for 64 resilient stocks with low risk scores. Spot strong balance sheets that can support future plans by scanning the solid balance sheet and fundamentals stocks screener (46 results).   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}